Strs Ohio Intercept Pharmaceuticals, Inc. Transaction History

Strs Ohio

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$12.21 - $19.7 $133,089 - $214,730	-10,900 Reduced 23.14%	36,200 $504,000
Q2 2022 Jul 25, 2022	BUY	$11.23 - $19.59 $217,862 - $380,046	19,400 Added 70.04%	47,100 $650,000
Q1 2022 Apr 21, 2022	SELL	$13.37 - $17.79 $312,858 - $416,286	-23,400 Reduced 45.79%	27,700 $450,000
Q3 2021 Oct 22, 2021	BUY	$12.99 - $20.47 $461,145 - $726,685	35,500 Added 227.56%	51,100 $758,000
Q2 2021 Jul 26, 2021	BUY	$15.46 - $24.5 $241,176 - $382,200	15,600 New	15,600 $311,000
Q3 2020 Dec 14, 2020	SELL	$39.09 - $53.44 $42,999 - $58,784	-1,100 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$46.7 - $92.04 $46,700 - $92,040	1,000 Added 1000.0%	1,100 $52,000
Q1 2020 Apr 23, 2020	SELL	$48.35 - $118.68 $91,865 - $225,492	-1,900 Reduced 95.0%	100 $6,000
Q4 2019 Jan 24, 2020	BUY	$57.36 - $124.1 $114,720 - $248,200	2,000 New	2,000 $247,000
Q2 2019 Jul 25, 2019	SELL	$77.77 - $120.68 $62,216 - $96,544	-800 Closed	0 $0
Q1 2019 Apr 19, 2019	SELL	$91.83 - $120.68 $45,915 - $60,340	-500 Reduced 38.46%	800 $89,000
Q4 2018 Jan 23, 2019	BUY	$85.79 - $126.46 $25,737 - $37,938	300 Added 30.0%	1,300 $131,000
Q3 2018 Oct 19, 2018	BUY	$88.49 - $127.55 $88,490 - $127,550	1,000 New	1,000 $126,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.